A detailed history of Addison Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Addison Advisors LLC holds 2,783 shares of NVS stock, worth $273,986. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,783
Previous 2,662 4.55%
Holding current value
$273,986
Previous $283,000 13.07%
% of portfolio
0.09%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$106.13 - $120.89 $12,841 - $14,627
121 Added 4.55%
2,783 $320,000
Q2 2024

Aug 05, 2024

BUY
$92.57 - $107.37 $32,492 - $37,686
351 Added 15.19%
2,662 $283,000
Q1 2024

May 06, 2024

BUY
$95.27 - $108.47 $2,095 - $2,386
22 Added 0.96%
2,311 $223,000
Q4 2023

Feb 02, 2024

BUY
$92.27 - $101.54 $19,284 - $21,221
209 Added 10.05%
2,289 $231,000
Q3 2023

Nov 07, 2023

BUY
$94.73 - $105.13 $22,924 - $25,441
242 Added 13.17%
2,080 $211,000
Q2 2023

Aug 03, 2023

BUY
$92.52 - $104.91 $16,746 - $18,988
181 Added 10.92%
1,838 $185,000
Q1 2023

May 09, 2023

SELL
$80.03 - $92.81 $5,041 - $5,847
-63 Reduced 3.66%
1,657 $152,000
Q4 2022

Feb 07, 2023

BUY
$75.55 - $92.52 $24,402 - $29,883
323 Added 23.12%
1,720 $156,000
Q3 2022

Oct 28, 2022

BUY
$74.61 - $87.26 $8,356 - $9,773
112 Added 8.72%
1,397 $106,000
Q2 2022

Aug 04, 2022

SELL
$80.52 - $93.75 $10,467 - $12,187
-130 Reduced 9.19%
1,285 $109,000
Q1 2022

Apr 29, 2022

BUY
$80.11 - $90.62 $70,817 - $80,108
884 Added 166.48%
1,415 $124,000
Q4 2021

Jan 31, 2022

BUY
$79.7 - $88.13 $7,332 - $8,107
92 Added 20.96%
531 $46,000
Q3 2021

Nov 08, 2021

BUY
$81.78 - $95.14 $1,144 - $1,331
14 Added 3.29%
439 $36,000
Q4 2020

Feb 02, 2021

BUY
$78.07 - $94.43 $33,179 - $40,132
425 New
425 $40,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.